Ocular Therapeutix (OCUL) Stock Insights

OCUL price $7.33 +0.04 +0.62%

Ticker
OCUL
Price
$7.33
Change
+0.04 +0.62%
Market cap ?
$1.61B
P/E ?
-4.56
Forward P/E ?
366.75
Dividend yield ?
0.00%
Beta ?
0.99
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
49
Value
58
Quality
34
Growth
54

Stocklytics score rationale: value 58, quality 34, growth 54.

Financials

2016201720182019202020212022202320242025
1887000192300019900004227000174030004352200051494000584430006372300051823000

Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage from corneal…

Fair value

OCUL fair value $2.05. Price $7.33. Price is 257% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 10.93M. Growth 1.83%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.76% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 219.62M. Net debt -657.28M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare OCUL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-0.36—14.27M
2026-08-03-0.35-0.4013.47M13.20M
2026-05-05-0.41-0.3210.79M12.72M
2026-02-05-0.29-0.3313.25M16.13M
2025-11-04-0.37-0.3914.54M16.14M
2025-08-05-0.39-0.3513.46M14.57M
2025-05-05-0.37-0.2910.63M13.10M
2025-03-03-0.29-0.2417.08M17.11M
2024-11-14-0.26-0.2315.43M16.89M
2024-08-07-0.24-0.2216.44M15.82M
2024-05-07-0.49-0.1814.77M15.36M
2024-03-11-0.28-0.2814.80M15.71M
2023-11-07-0.51-0.2915.08M15.23M
2023-08-07-0.27-0.2915.19M14.65M
2023-05-08-0.31-0.2713.37M14.10M
2023-03-06-0.24-0.2514.08M13.53M
2022-11-07-0.30-0.2311.96M14.27M
2022-08-08-0.28-0.2312.27M14.25M
2022-05-09-0.22-0.2513.19M13.96M
2022-02-28-0.23-0.2312.31M13.94M
2021-11-08-0.23-0.2612.15M13.88M
2021-08-09-0.25-0.2011.72M11.72M
2021-05-05-0.24-0.207.34M9.76M
2021-03-11-0.23-0.187.35M—
2020-11-05-0.17-0.235.88M1.94M
2020-08-07-0.34-0.321.57M1.27M
2020-05-08-0.41-0.402.61M2.35M
2020-03-12-0.47-0.422.26M1.92M
2019-11-12-0.45-0.46829.00K974.08K
2019-08-07-0.57-0.42650.00K547.37K
2019-05-10-0.45-0.42492.00K504.00K
2019-03-07-0.42-0.37504.00K456.00K
2018-11-07-0.38-0.36498.00K498.00K
2018-08-07-0.37-0.37648.00K648.00K
2018-05-08-0.40-0.39340.00K323.00K
2018-03-08-0.44-0.58487.00K575.55K
2017-11-07-0.54-0.54523.00K513.31K
2017-08-08-0.64-0.59438.00K383.25K
2017-05-05-0.58-0.48475.00K393.10K
2017-03-10-0.45-0.47511.00K442.21K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-08Anderman ToddSell11.98K$7.2987.36K
2026-10-02Kaiser PeterSell9.99K$7.0570.43K
2026-10-02Heier Jeffrey S.Sell10.87K$7.0576.63K
2026-08-31Notman DonaldSell1.10K$10.2411.25K
2026-08-25Dugel PravinBuy50.09K——
2026-08-25Dugel PravinSell50.09K——
2026-08-24Kaiser PeterSell3.04K$10.7732.69K
2026-08-24Nayak SanjaySell1.90K$10.7820.45K
2026-08-24Heier Jeffrey S.Sell3.30K$10.7835.53K
2026-08-24Dugel PravinSell21.65K$10.77233.16K
2026-06-16Dugel PravinSell50.09K——
2026-06-16Dugel PravinBuy50.09K——
2026-06-10Warden Charles MBuy14.00K——
2026-06-10Warden Charles MBuy44.00K$8.74384.56K
2026-06-10Graves Adrienne LBuy14.00K——
2026-06-10Graves Adrienne LBuy44.00K$8.74384.56K
2026-06-10Robins Jason ShandBuy15.44K——
2026-06-10Robins Jason ShandBuy14.02K$8.74122.57K
2026-06-10Hong Seung SuhBuy14.00K——
2026-06-10Hong Seung SuhBuy44.00K$8.74384.56K
2026-06-10LINDSTROM RICHARD L MDBuy14.00K——
2026-06-10LINDSTROM RICHARD L MDBuy44.00K$8.74384.56K
2026-06-10RAINES MERILEEBuy14.00K——
2026-06-10RAINES MERILEEBuy44.00K$8.74384.56K
2026-06-10Williams Leslie J.Buy14.00K——
2026-06-10Williams Leslie J.Buy44.00K$8.74384.56K
2026-06-03Waheed NadiaSell14.83K$8.27122.63K
2026-05-28Dugel PravinBuy394.70K——
2026-05-28Dugel PravinSell394.70K——
2026-05-26Dugel PravinSell21.16K$8.20173.48K
2026-05-26Kaiser PeterSell2.97K$8.2024.33K
2026-05-26Heier Jeffrey S.Sell3.02K$8.2024.75K
2026-05-26Nayak SanjaySell1.86K$8.2015.24K
2026-04-09Dugel PravinSell394.70K——
2026-04-09Dugel PravinBuy394.70K——
2026-02-23Dugel PravinSell20.06K$8.28166.06K
2026-02-23Kaiser PeterSell2.81K$8.2823.27K
2026-02-23Heier Jeffrey S.Sell3.06K$8.2825.31K
2026-02-23Nayak SanjaySell1.76K$8.2814.56K
2026-02-20Waheed NadiaSell3.51K$7.7427.17K
2026-02-20LINDSTROM RICHARD L MDBuy60.23K$7.66461.35K
2026-02-12Notman DonaldSell11.45K$9.04103.47K
2026-02-12Nayak SanjaySell10.35K$9.0493.55K
2026-02-12Dugel PravinSell124.88K$9.041.13M
2026-02-12Waheed NadiaSell7.86K$9.0471.08K
2026-02-04Notman DonaldSell6.04K$8.5451.54K
2026-02-02Notman DonaldSell5.46K$9.1449.86K
2026-01-21Robinson David WayneBuy416.00K$11.424.75M
2026-01-21Robinson David WayneBuy136.00K——
2026-01-21Robinson David WayneOther0——
2026-01-20Robins Jason ShandBuy33.00K$11.45377.85K
2026-01-20Robins Jason ShandOther0——
2026-01-20Robins Jason ShandOther68.19K$11.82806.06K
2026-01-20Robins Jason ShandOther110.60K$8.12898.07K
2026-01-02Anderman ToddBuy197.65K$11.822.34M
2026-01-02Anderman ToddBuy64.90K——
2026-01-02Meyers Steve LawrenceBuy64.90K——
2026-01-02Meyers Steve LawrenceBuy197.65K$11.822.34M
2026-01-02Nayak SanjayBuy64.90K——
2026-01-02Nayak SanjayBuy197.65K$11.822.34M
2026-01-02Kaiser PeterBuy79.11K——
2026-01-02Kaiser PeterBuy240.93K$11.822.85M
2026-01-02Saroj NamrataBuy79.11K——
2026-01-02Saroj NamrataBuy240.93K$11.822.85M
2026-01-02Waheed NadiaBuy79.11K——
2026-01-02Waheed NadiaBuy240.93K$11.822.85M
2026-01-02Heier Jeffrey S.Buy79.11K——
2026-01-02Heier Jeffrey S.Buy240.93K$11.822.85M
2026-01-02Notman DonaldBuy79.11K——
2026-01-02Notman DonaldBuy240.93K$11.822.85M
2025-11-26Dugel PravinBuy49.75K——
2025-11-26Dugel PravinSell49.75K——
2025-11-24Nayak SanjaySell1.88K$12.0422.61K
2025-11-24Dugel PravinSell19.53K$12.04235.14K
2025-11-24Kaiser PeterSell3.01K$12.0236.14K
2025-11-24Heier Jeffrey S.Sell3.47K$12.0441.77K
2025-11-05Saroj NamrataSell25.86K$10.74277.79K
2025-10-08Anderman ToddSell11.13K$12.34137.37K
2025-10-02Kaiser PeterSell9.65K$11.03106.47K
2025-10-02Heier Jeffrey S.Sell10.50K$11.04115.94K
2025-09-09Dugel PravinSell49.75K——
2025-09-09Dugel PravinBuy49.75K——
2025-09-02Notman DonaldSell1.07K$12.4313.25K
2025-08-25Kaiser PeterSell3.01K$12.0436.25K
2025-08-25Nayak SanjaySell1.89K$12.0422.70K
2025-08-25Heier Jeffrey S.Sell3.06K$12.0436.88K
2025-08-25Dugel PravinSell21.49K$12.04258.79K
2025-08-12Waheed NadiaBuy40.36K——
2025-08-12Waheed NadiaBuy122.92K$12.481.53M
2025-08-11Dugel PravinBuy250.36K——
2025-06-12Dugel PravinSell50.03K——
2025-06-11Meyers Steve LawrenceOther0——
2025-06-11Meyers Steve LawrenceOther45.00K$5.22234.90K
2025-06-11Meyers Steve LawrenceOther222.00K$7.441.65M
2025-06-11Meyers Steve LawrenceOther145.00K$5.18751.10K
2025-06-11Meyers Steve LawrenceOther100.00K$3.88388.00K
2025-06-11Saroj NamrataOther0——
2025-06-11Saroj NamrataOther100.00K$9.95995.00K
2025-06-11Saroj NamrataOther316.00K$10.273.25M
2025-06-11Dugel PravinBuy2.75M$7.4420.46M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 277, holders -11 vs prior quarter. Ownership 93.14%.

HolderSharesChangeChange %Value
FMR LLC32.84M190.28K+0.58%322.53M
DEEP TRACK CAPITAL, LP19.69M00.00%193.32M
BLACKROCK, INC.19.38M3.24M+20.11%190.28M
AVORO CAPITAL ADVISORS LLC12.54M225.00K+1.83%123.14M
SUMMER ROAD LLC12.21M328.47K+2.76%119.89M
VENROCK ADVISER, LLC10.35M00.00%101.61M
VANGUARD CAPITAL MANAGEMENT LLC8.83M113.56K+1.30%86.74M
PRICE T ROWE ASSOCIATES INC /MD/7.62M1.73M+29.27%74.86M
LOGOS GLOBAL MANAGEMENT LP5.30M1.45M+37.66%52.05M
STATE STREET CORP5.23M524.86K+11.15%51.39M
GEODE CAPITAL MANAGEMENT, LLC5.02M491.91K+10.86%49.32M
POINT72 ASSET MANAGEMENT, L.P.3.29M-2.24M-40.52%32.33M
DIMENSIONAL FUND ADVISORS LP2.78M2.13M+328.37%27.33M
DELTEC ASSET MANAGEMENT LLC2.48M135.58K+5.79%24.32M
BALYASNY ASSET MANAGEMENT L.P.2.27M-421.92K-15.67%22.30M
OCTAGON CAPITAL ADVISORS LP2.08M-1.09M-34.47%20.38M
VANGUARD PORTFOLIO MANAGEMENT LLC1.97M378.46K+23.73%19.38M
NORTHERN TRUST CORP1.80M273.80K+17.95%17.67M
GOLDMAN SACHS GROUP INC1.76M651.39K+58.66%17.30M
NUVEEN, LLC1.70M1.29M+312.88%16.67M
WOODLINE PARTNERS LP1.67M00.00%16.38M
TCG CROSSOVER MANAGEMENT, LLC1.65M00.00%16.18M
UBS GROUP AG1.55M30.37K+2.00%15.23M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.55M1.55MNew15.22M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.53M1.53MNew15.06M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Ocular Therapeutix (OCUL) Stock Insights

OCUL$7.33+0.04 +0.62%

$1.61B

Market Cap

-4.56

P/E

366.75

Forward P/E

49

Score

Price History